Beneficial effects of traditional Chinese medicine on the treatment of osteoporosis on ovariectomised rat models

Current Drug Targets

Volumn 14, Issue 14, 2013, Pages 1689-1693

  Rufus, Pamela ^a   Mohamed, Norazlina ^a   Shuid, Ahmad Nazrun ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Bone disorder; Herbal drugs; Hormone replacement therapy; Osteoporosis; Traditional chinese medicine

Indexed keywords

ACHYRANTHES BIDENTATA EXTRACT; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; ANTIOXIDANT; BONE MORPHOGENETIC PROTEIN; CALCITONIN; CALCIUM; ER ZHI WAN; ESTROGEN; OSTEOCALCIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VITAMIN D;

ACHYRANTHES BIDENTATA; BONE DENSITY; BONE MASS; BONE STRENGTH; BONE TURNOVER; CELL VIABILITY; CHINESE MEDICINE; CIBOTIUM BAROMETZ; CURCULIGO ORCHIOIDES; DAVALLIA FORMOSANA; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; MEDICINAL PLANT; NONHUMAN; OSTEOPOROSIS; POLYGONATUM; POLYGONATUM SIBIRICUM; REVIEW;

ANIMALS; BONE RESORPTION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; ESTROGENS; FEMALE; MEDICINE, CHINESE TRADITIONAL; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PLANTS, MEDICINAL; RATS;

EID: 84891682060     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450114666131220160357     Document Type: Review

References (41)

1. Renno AC, de Moura FM, dos Santos NS, Tirico RP, Bossini PS, Parizotto NA. Effects of 830-Nm Laser, used in two doses, on biomechanical properties of osteopenic rat femur. Photomed Laser Surg 2006; 24: 202-6
2. Genant HK, Delmas PD, Chen P, et al. Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 2007; 18: 69-76.
3. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med 2011; 17(10): 1235-41.
4. Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective. How many women have osteoporosis? J Bone Miner Res 1992; 7: 1005-10.
5. Chung HY, Sung B, Jung KJ, Zou Y, Yu BP. The molecular inflammatory process in aging. Antioxid Redox Signal 2006; 8(3-4): 572-81.
6. Thompson DD, Simmons HA, Pirie CM, et al. FDA guidelines and animal models for osteoporosis. Bone 1995; 17: 125-33.
7. Harper KD, Weber TJ. Secondary Osteoporosis. Diagnostic considerations. Endocrinol Metab Clin N Am 1998; 27: 325-48.
8. Stevenson JC. Justification for the use of HRT in the long-term prevention of osteoporosis. Mauritas 2005; 51(2): 113-26.
9. Prelevic GM, Kocjan T, Markou A. Hormone replacement therapy in post-menopausal women. Minerva Endocrinol 2005; 30: 27-36.
10. Canderelli R, Leccesse LA, Miller NL, et al. Benefits of hormone replacement therapy in postmenopausal women. J Am Acad Nurse Pract 2007; 19: 635-41.
11. Li XM, Brown L. Efficacy and mechanisms of action of traditional Chinese medicine for treating allergy and asthma. J Allergy Clin Immunol 2009; 132, 297-306
12. Cuong NX, Minh CV, Kiem PV, et al. Inhibitors of Osteoclast formation from rhizomes of Cibotium barometz. J Nat Prod 2009; 72: 1673-7.
13. Wu Q, Yang XW, Yang SH, et al. Yan Chemical constituents of Cibotiumbarometz. Natural Product Research and Development 2007: 240-3
14. Zhao X, Wu ZX, Zhang Y, et al. Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats. J Ethnopharmacol 2011; 137(3): 1083-8.
15. Li JX, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S. Five new oleanoic acid glycosides from Achyranthes bidenta with inhibitory activity on osteoclast formation. Planta Med 2005; 71: 673-9.
16. Zhang H, Xing WW, Li YS, et al. Effects of a traditional Chinese herbal Preparation on osteoblasts and osteoclasts. Maturitas 2008; 61(4): 334-9.
17. Nicolov S, Thuan N, Zhelzazlov V. Flavonoids from Achyranthes bidentata BI. Acta Hoctic 1996, 426.
18. Rong Z, Shi-jie H, Chen Li et al. Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats. J EthnoPharmaco 2012; 139: 12-8.
19. He CC, Hui RR, Tezuka Y, Kadota S, Li JX. Osteoprotective effect of extract from Achyranthes bidentata in ovariectomised rats. J EthnoPharmaco 2010; 127(2): 229-34.
20. Matsuo K. Cross talks among bone cells. Curr Opin Nephrol Hypertens 2009; 18(4): 292-7.
21. Lu DN. Effect of ER-ZHI-WAN on Kidney disease. Henan Trad Chin Med 2007; 27: 51-2
22. Cheng M, Wang Q, Fan Y, et al. A traditional Chinese herbal preparation, ER-ZHI-WAN, prevent ovariectomy-induced osteoporosis in rats. J Ethnopharmacol 2011; 138: 279-85.
23. Zhang Y, Li XL, Lai WP, et al. Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. J EthnoPharmaco 2007; 109: 165-9
24. Zhu X, Luo J, Chen X, et al. Expression characteristic and significance of interleukin-6, nuclear factor kappa beta, and bone formation markers in rat models of osteoporosis. Transl Res 2008; 152(1): 18-23.
25. Sun JS, Dong GC, Lin CY, et al. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) immobilized modified calcium hydrogenphosphate on bone cell activities. Biomaterials 2003; 24: 873-82
26. Ma, R, Wang R, Qiu M. Study of morphologic effects of 4 Chinese herbs by bone histomorphometry in ovariectomized rats. Zhonghua Fu Chan Ke Za Zhi 1999; 34: 82-5.
27. Ko YJ, Wu JB, Ho HY, Lin WC. Antiosteoporotic activity of Davallia formosana. J Ethnopharmacol 2012; 139(2): 558-65.
28. Sun JS, Dong GC, Lin CY, et al. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) immobilized modified calcium hydrogenphosphate on bone cell activites. Biomaterials 2003; 24(5): 873-82.
29. Dong GC, Chen HM, Yao CH. A novel bone substitute composite composed of tricalcium phosphate, gelatin andDrynaria fortunei herbal extract. J Biomed Mater Res A 2008; 84(1): 167-77.
30. Shuid AN, Ping LL, Muhammad N, Mohamed N, Soelaiman IN. The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis. J Ethnopharmacol 2011; 133(2): 538-42.
31. Zeng GF, Zhang ZY, Lu L, et al. Protective effects of Polygonatum sibiricum polysaccharide on ovariectomy-induced bone loss in rats. J Ethnopharmacol 2011; 136(1): 224-9.
32. Shi YY, Shi Y, Zhang HS. Advantage and disadvantage of TCM in prevention and treatment of osteoporosis. Acta Univ Trad Med Sin Pharmacol Shanghai 2006; 20: 1-3.
33. Nian LP, Qin QY, Zhang HC, et al. Antiosteoporotic activity of Er- Xian Decoction, a traditional Chinese herbal formula, in ovariectomized rats. J Ethnopharmacol 2006; 108: 96-102.
34. Tiwari RD, Misra G. Structural studies of the constituents of the rhizomes of Curculigo orchioides. Planta Med 1976; 26: 291-4.
35. Cao PD, Zheng YN, Qin LP, et al. Curculigo orchioides prevents bone loss in ovariectomides rats. Mauritus 2008; 59: 373-80.
36. Mehta BK, Dubey A. Bokadia MM. A new aliphatic long-chain methoxyketone from Curculigo orchioides roots. Indian J Chem 1983; 22: 282-3.
37. Nakagawa T, Yokozawa T, Yamabe N, et al. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats. J Pharm Pharmacol 2005; 57: 1205-12.
38. Yamabe N, Yokozawa T, Kim HY, et al. Protective effect of against renal failure in a subtotal nephrectomy rat model. J Pharm Pharmacol 2005; 57: 1637-44.
39. Usuki S. Hachimijiogan produces testosterone in adult rat testes. Am J Chin Med 1988; 16: 93-105.
40. Ikeda R, Mizoguchi K. Hachimijiogan (Ba-Wei-Di-Huang-Wan), a herbal medicine, improves unbalance of calcium metabolism in aged rats. J Ethnopharmacol 2009; 129: 176-81.
41. Huaye C, Mishan W, Kin-ya K. Combined treatment with a traditional Chinese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang- Wan) and alendronate bone microstructure in ovariectomised rats. J Ethnopharmaco 2012; 142: 80-5.